Vitamin D3 (also known as Cholecolciferol) has generated a lot of great buzz lately in formulation circles, and consumer awareness of this ingredient is increasing exponentially due positive press associated with recent studies involving this ingredient. Research studies from highly respected organizations have theorized this ingredient to have potential impact on a wide variety of health conditions including immunomodulation, various forms of cancer, cardiovascular disease and mortality. Further generating positive press was the US Food and Drug Administration’s amended health claim on calcium and osteoporosis, which now includes vitamin d. This new ruling removed many of the historical limitations associated with the claim and specified the ability to clarify the role Vitamin D  plays in the body’s ability to absorb calcium. Though this ruling did not became effective until January 1, 2010, manufacturers were permitted to use the claim as early as September 2009.

AIC is proud to be partnered with Fermenta Biotech and Supreem Pharmaceuticals to offer a Vitamin D3 to product developers in the US in a variety forms to meet their specific formulation requirements.

Supreem Pharmaceuticals, India’s most reputed company in the field of Stabilized Vitamins, uses proprietary processing techniques to manufacture Vitamin D3 in cold water dispersable and coated forms for numerous applications.

Fermenta Biotech, India’s first and still the only manufacturer of Vitamin D3, uses over 25 years experience to bring the highest quality, highest purity Vitamin D3 to discerning finished product managers worldwide.

Vitamin D3 and AIC – Many practical applications, one logical source.

For more information and samples contact info@aicma.com or visit www.aicma.com.